Polycythemia Vera Treatments

Find Polycythemia Vera Treatments

Medications for Polycythemia Vera

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Polycythemia Vera.

Found 1 Approved Drug for Polycythemia Vera

Ruxolitinib

Brand Names
Jakafi, Opzelura

Ruxolitinib

Brand Names
Jakafi, Opzelura
Jakafi is a kinase inhibitor indicated for treatment of: intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis in adults.
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances